| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-13 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-12 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |